ReflexMD and Tirzepatide: The Dual-Agonist, Reviewed

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This PlexusDx Education Hub article focuses on one compound, tirzepatide, and how telehealth programs prescribe it. Browse all Peptides & GLP-1 education

This is an independent, unsponsored review. PlexusDx has no commercial relationship with ReflexMD and earns no affiliate revenue from any brand discussed.

Searching "ReflexMD tirzepatide" points to a specific interest in the compound itself, not just the program. This review centers on tirzepatide, how it is supplied, what the evidence shows, and the biology it acts on. Details reflect April 2026 and should be verified directly.

Tirzepatide, the dual agonist behind the program

Tirzepatide is distinct from single-target GLP-1 medications because it activates two receptors: GIP and GLP-1. This dual action influences appetite regulation, satiety signaling, and gastric emptying. Any legitimate program prescribing it, ReflexMD included, is delivering that same underlying pharmacology; the compound, not the platform, drives the mechanism.

Compounded tirzepatide versus branded Mounjaro and Zepbound

Tirzepatide reaches patients two ways. FDA-approved branded products such as Mounjaro and Zepbound are dispensed through retail pharmacies, while compounded tirzepatide is prepared by a licensed 503A compounding pharmacy under an individual prescription. The active compound is the same class; the supply pathway, and the regulatory framework around it, differ.

How a telehealth program like ReflexMD dispenses tirzepatide

In the telehealth-plus-compounded-pharmacy model, you complete an intake, a licensed clinician reviews eligibility, and, if appropriate, a prescription is routed to either a retail or a compounding pharmacy. Follow-up then supports dose titration and side-effect management as the dose steps up over the early weeks. Which pathway applies depends on the program and the product chosen.

Tirzepatide is typically titrated gradually rather than started at a target dose, which is why ongoing follow-up matters more here than the initial prescription. A program's real value on this compound shows up in how it manages that ramp: whether a clinician is reachable when nausea or other early effects appear, and whether dose adjustments are handled thoughtfully rather than automatically.

Because tirzepatide is a distinct compound rather than a version of semaglutide, it is worth confirming exactly what a program dispenses. A plan marketed generically as "GLP-1 therapy" may default to semaglutide unless tirzepatide is specifically requested, so clarify the compound, the strength, and the supply pathway before assuming which molecule you will receive.

What the SURMOUNT evidence shows

Tirzepatide's clinical record centers on the SURMOUNT program for weight management, published in The New England Journal of Medicine in 2022, with SURMOUNT-OSA extending study to obstructive sleep apnea in 2024. Trial populations and endpoints vary, and individual outcomes vary as well; the evidence describes averages, not a personal guarantee.

The genetic terrain tirzepatide acts on

Even the right compound is prescribed into biology a telehealth intake cannot see. Variants in GLP1R (a receptor tirzepatide engages), FTO, MC4R, and TCF7L2 map the metabolic baseline at the pathway level. They do not predict how you will respond to tirzepatide, but they describe the terrain a clinician prescribes into. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights.

Tirzepatide with genetic context at PlexusDx

PlexusDx offers tirzepatide within its Weight Management Protocols, including Tirzepatide Injection at $289 per month, alongside Semaglutide Injection at $189 per month. What differs is the upstream genetic context paired with the protocol, turning a prescription into an informed conversation.

Not affiliated: PlexusDx has no partnership with or commercial tie to ReflexMD, Eli Lilly, or any brand named here.

Related reading: Weight Loss Injections Mounjaro, Cost Of Mounjaro, Eli Lilly Mounjaro, and Mounjaro Injection Sites.

Frequently Asked Questions About ReflexMD and Tirzepatide

Is ReflexMD's tirzepatide the same as Mounjaro?

Mounjaro is an FDA-approved branded tirzepatide product. A telehealth program may dispense either branded tirzepatide or compounded tirzepatide from a 503A pharmacy. The compound class is the same, but the branded product and a compounded preparation follow different regulatory and supply pathways.

What's the difference between compounded and branded tirzepatide?

Branded tirzepatide, such as Mounjaro or Zepbound, is an FDA-approved product dispensed through retail pharmacies. Compounded tirzepatide is prepared by a licensed 503A pharmacy under an individual prescription. They share the compound class but differ in regulatory status, oversight, and how they are supplied.

How does ReflexMD prescribe tirzepatide?

In this model, you complete an intake, a licensed clinician reviews eligibility, and a prescription is routed to a retail or compounding pharmacy, followed by monitoring during dose titration. Exact program mechanics and available products should be confirmed on the brand's own website before enrolling.

Does a genetic test predict my tirzepatide response?

No. The Precision Peptide Genetic Test does not predict response to tirzepatide or any specific medication. It maps pathway-level variants such as GLP1R, FTO, and MC4R that describe your baseline metabolic biology, offering context for a discussion with your clinician rather than a prediction.

Continue in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Editorial note: This independent article is educational. PlexusDx is not affiliated with ReflexMD and offers its own Weight Management Protocols; the Precision Peptide Genetic Test analyzes peptide pathways and does not predict medication response. Consult a qualified healthcare provider before beginning any protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.